Kathleen M Gillooly Selected Research

4(2'- aminoethyl)amino- 1,8- dimethylimidazo(1,2- a)quinoxaline

11/2009	Periodic, partial inhibition of IkappaB Kinase beta-mediated signaling yields therapeutic benefit in preclinical models of rheumatoid arthritis.
9/2003	A highly selective inhibitor of I kappa B kinase, BMS-345541, blocks both joint inflammation and destruction in collagen-induced arthritis in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kathleen M Gillooly Research Topics

Disease

7	Inflammation (Inflammations) 08/2011 - 05/2003
5	Rheumatoid Arthritis 01/2017 - 09/2003
3	Experimental Arthritis 01/2017 - 09/2003
3	Arthritis (Polyarthritis) 01/2017 - 09/2003
2	Autoimmune Diseases (Autoimmune Disease) 11/2020 - 01/2019
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019
1	Lupus Nephritis 01/2019
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2006
1	Hypersensitivity (Allergy) 10/2006
1	Melanoma (Melanoma, Malignant) 10/2006
1	Pneumonia (Pneumonitis) 10/2006

Drug/Important Bio-Agent (IBA)

4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2009 - 10/2006
3	Phosphotransferases (Kinase)IBA 11/2020 - 09/2010
2	LigandsIBA 01/2021 - 05/2003
2	I-kappa B KinaseIBA 11/2009 - 09/2003
2	4(2'- aminoethyl)amino- 1,8- dimethylimidazo(1,2- a)quinoxalineIBA 11/2009 - 09/2003
2	CytokinesIBA 11/2006 - 09/2003
2	NF-kappa B (NF-kB)IBA 10/2006 - 09/2003
1	pyridazineIBA 01/2021
1	deucravacitinibIBA 01/2019
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2017
1	CollagenIBA 01/2017
1	KetonesIBA 08/2011
1	benzocycloheptapyridineIBA 01/2011
1	LipopolysaccharidesIBA 11/2009
1	2- methoxy- N- ((6- (1- methyl- 4- (methylamino)- 1,6- dihydroimiazo(4,5- d)pyrrolo(2,3- b)pyridin- 7- yl)pyridin- 2- yl)methyl)acetamideIBA 11/2009
1	Dihydrotachysterol (AT 10)IBA 11/2009
1	BMS-640994IBA 03/2008
1	TriazinesIBA 01/2008
1	AmidesIBA 01/2008
1	EstersIBA 01/2008
1	Dasatinib (BMS 354825)FDA Link 11/2006
1	Interleukin-2 (IL2)IBA 11/2006
1	BMS-470539IBA 10/2006
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2006
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 10/2006
1	Type 1 Melanocortin ReceptorIBA 10/2006
1	Collagen Type II (Type II Collagen)IBA 09/2003
1	EnzymesIBA 09/2003
1	Cell Adhesion MoleculesIBA 09/2003
1	CannabinoidsIBA 05/2003
1	CB2 Cannabinoid ReceptorIBA 05/2003